Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial

Experimental studies provide evidence for antidepressant effects of Palmitoylethanolamide (PEA) in animal models of depression. We aimed to evaluate the efficacy and tolerability of PEA add-on therapy in treatment of patients with major depressive disorder (MDD). In a randomized double-blind, and pl...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of affective disorders 2018-05, Vol.232, p.127-133
Hauptverfasser:	Ghazizadeh-Hashemi, Maryam, Ghajar, Alireza, Shalbafan, Mohammad-Reza, Ghazizadeh-Hashemi, Fatemeh, Afarideh, Mohsen, Malekpour, Farzaneh, Ghaleiha, Ali, Ardebili, Mehrdad Eftekhar, Akhondzadeh, Shahin
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-inflammatory Glutamate Major Depressive Disorder (MDD) Palmitoylethanolamide (PEA) PPAR-α agonists
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!